SERB Pharmaceuticals
SERB Pharmaceuticals (previously BTG) are a pharmaceutical company developing drugs for emergency care and rare diseases. SERB acquired BTG Specialty Pharmaceuticals in 2021, who had a portfolio of emergency care medicines, including antivenins developed by Protherics who BTG acquired in 2008. Protherics have a manufacturing facility in Llandysul